10X GENOMICS INC-CLASS A (TXG)
US88025U1097 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -182.55M | -255.10M | -166.00M | -58.22M | -542.73M | |||
| Depreciation Amortization | 36.84M | 35.51M | 25.37M | 21.12M | 14.01M | |||
| Change In Working Capital | 19.69M | 17.34M | -39.42M | -87.45M | -50.38M | |||
| Interest Paid | -4.00K | 436.00K | 840.00K | 1.22M | 1.67M | |||
| Taxes Paid | 5.34M | 4.93M | 3.93M | 8.66M | 280.00K | |||
| Other non cash items | 165.18M | 187.05M | 146.44M | 103.18M | 361.20M | |||
| OPERATING CASH FLOW | 39.17M | -15.20M | -33.61M | -21.37M | -217.90M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -14.13M | -49.52M | -131.66M | -101.28M | -38.39M | |||
| Other Investing Activity | 46.18M | 183.02M | -219.23M | -5.45M | N/A | |||
| INVESTING CASH FLOW | 32.06M | 133.49M | -350.89M | -106.73M | -38.39M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | 0.00 | -31.26M | |||
| Stock Issued/Repurchased | 12.01M | 19.48M | 21.23M | 40.33M | 506.01M | |||
| Other Financing Activity | -4.00K | -5.81M | -5.41M | -5.03M | -5.85M | |||
| FINANCING CASH FLOW | 12.01M | 13.67M | 15.82M | 35.30M | 468.91M | |||
| Exchange Rate Effect | 182.00K | -33.00K | -40.00K | 230.00K | -460.00K | |||
| CHANGE IN CASH | 83.43M | 131.93M | -368.72M | -92.57M | 212.16M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 39.17M | -15.20M | -33.61M | -21.37M | -217.90M | |||
| Capital Expenditure | -14.13M | -49.52M | -131.66M | -101.28M | -38.39M | |||
| FREE CASH FLOW | 25.04M | -64.72M | -165.27M | -122.65M | -256.29M | |||
All data in USD